HealthTech Articles

It is a known fact that most internationalization attempts fail due to lack of thorough preparation and adhering to the chosen strategy.

When it comes to life sciences – healthcare technology, biomedical technology and pharmaceuticals – that is an industry operating in a heavily regulated environment, any attempt to seek market growth through internationalization faces a multitude of specific considerations.

On 22nd May an online pitching for HealthTech Startups is organized by inXso together with Slush China to Venture Capital investors of which there is a significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma and BioMedTech.

In our series focusing on Health Tech in Chinese market inXso is organizing an interactive webinar “Health Tech China Focus” together with Tampere HealthHUB that will briefly discuss some of the key points and rather unique aspects of Chinese Health Tech initiatives and their implementation.